RVMD vs RYTM Stock Comparison

RYTM currently leads RVMD in this stock comparison, with AIQ scores of 62 vs 55. The clearest difference is quality.

Market data as of Nov 15, 2026 market close· AIQ score gap 7 points
RVMD
Healthcare
vs
RYTM
Healthcare
RVMD
Revolution Medicines, Inc.
Price
$172
Day move
-2.3%
AIQ Score
55/100
Best edge
Balanced
Sector
Healthcare
RYTM
Rhythm Pharmaceuticals, Inc.
Leads
Price
$115
Day move
+4.7%
AIQ Score
62/100
Best edge
Quality
Sector
Healthcare

What is the main difference between RVMD and RYTM?

RYTM leads the current stock comparison as Rhythm Pharmaceuticals, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Revolution Medicines, Inc. vs Rhythm Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

RYTM leads

RYTM leads by 7 AIQ points, primarily on Quality and Value, having only recently taken the lead back from RVMD. Wall Street currently favors RVMD on target upside.

Fragile: 3 of 6 evidence groups support RYTM, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Reversed
RVMD

Revolution Medicines, Inc.

AIQ Score
55/100
AIQ Edge Score
5/10
RYTM

Rhythm Pharmaceuticals, Inc.

Leads
AIQ Score
62/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors RYTM over RVMD, 62 versus 55 as of Nov 15, 2026. RYTM's advantage is driven primarily by stronger quality and value. RYTM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RVMD. 3 of 6 covered evidence groups favor RYTM today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. RYTM lead: Reversed — RVMD led by 9 AIQ points 30 sessions ago; RYTM now leads by 7.

Compare Revolution Medicines, Inc. and Rhythm Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

RVMD
+456.0%
RYTM
+858.5%

Price return comparison

Growth of $10,000, price only

RVMD $55,595 · RYTM $95,850

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare RVMD and RYTM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

RVMD advantage
0
RYTM advantage
  • Quality43 vs 60
    RYTM +17
  • Value39 vs 52
    RYTM +13
  • Risk Resilience59 vs 57
    Even
  • Momentum73 vs 72
    Even

3 of 6 evidence groups favor RYTM. RYTM’s edge is concentrated in quality and value.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

RVMD+1 AIQ

Largest factor move: Momentum +2

New signals

  • BB Lower Band Breach — bullish, volatility, short horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon
RYTM+2 AIQ

Largest factor move: Momentum +4

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon

RYTM's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — RVMD and RYTM both carry a full feed there.

The central trade-off

RYTM (Rhythm Pharmaceuticals, Inc.): the stronger current systematic profile, led by quality and value.

RVMD (Revolution Medicines, Inc.): the counter-case, on fundamentals, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

RYTM

RYTM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

RYTM

RYTM on combined revenue and EPS growth.

Value

RYTM

RYTM on the peer-relative Value factor, by 13 points.

Momentum

Even

The two are level on Momentum.

Lower downside

RVMD

RVMD carries the lower 1-month annualized volatility.

Analyst upside

RVMD

RVMD on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors RYTM, analyst targets favor RVMD. That disagreement is the most useful thing on this page.

MeasureRVMDRYTMNote
Implied upside to target+52.3%+18.5%RVMD has more room
Target dispersion+53.7%+28.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2519Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor RYTM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreRYTM55 vs 62
FundamentalsRVMDEPS growth 37.9% vs 16.4%; TTM ROE -17% vs -20.5%; gross margin 95.2% vs 88.2%; operating margin -8.5% vs -66.7%
ValuationRYTMValue 39 vs 52
TechnicalsRYTMPrice vs 50-day -11.4% vs 18.7%; vs 200-day 7.8% vs 18.3%
Risk ResilienceEvenRisk Resilience 59 vs 57
Analyst expectationsRVMDTarget upside 52.3% vs 18.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of RVMD and RYTM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 7 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on RYTM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

RYTM lead: Reversed — RVMD led by 9 AIQ points 30 sessions ago; RYTM now leads by 7.

May 27RVMD leads above the line · RYTM leads belowNov 13
Today
RYTM +7
55 vs 62
7 sessions ago
Level
57 vs 57
30 sessions ago
RVMD +9
64 vs 55
90 sessions ago
RVMD +7
69 vs 62

The lead changed hands 2 times in this window, most recently on Nov 11 when RYTM moved ahead of RVMD.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

RVMDConflicted

3 bullish / 3 bearish / 1 neutral, conflicted

Only RVMD

  • Golden Cross Active — bullish, trend, long horizon (21.63%)
  • BB Lower Band Breach — bullish, volatility, short horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.12x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon
RYTMConflicted

3 bullish / 3 bearish / 2 neutral, conflicted

Only RYTM

  • Death Cross Active — bearish, trend, long horizon (0.37%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.64x)
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, Beta Spike Warning.

RYTM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

RVMDDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.3%, AIQ +1 points).

RYTMConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +4.7%, AIQ +2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1RVMD closes the Quality gap — currently 17 points behind, the largest single contributor to RYTM's edge.
  2. 2RVMD's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3RYTM's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

RVMD leads on balance
MetricRVMDRYTM
Revenue growth (YoY)0%29.3%
EPS growth (YoY)37.9%16.4%
Gross margin95.2%88.2%
Operating margin-8.5%-66.7%
Return on equity (TTM)-17%-20.5%
Debt to equity0.270.02

Performance

RYTM leads 4 of 6 windows
MetricRVMDRYTM
1 week (5 sessions)-10.4%2.4%
1 month (20 sessions)-3.2%33.5%
3 months (63 sessions)-18.7%-0.4%
6 months (126 sessions)18.3%27.1%
Year to date116.3%7.5%
1 year (252 sessions)161.7%17.5%

Technicals

RYTM has the stronger structure
MetricRVMDRYTM
RSI (14)39.766.3
ADX (14)17.628.5
Price vs 50-day-11.4%18.7%
Price vs 200-day7.8%18.3%
Volatility (1M, annualized)71%110.9%

Risk

Split
MetricRVMDRYTM
Beta1.31.24
Sharpe ratio1.690.52
Sortino ratio3.540.89
Max drawdown-25%-35.5%
Current drawdown-22.1%-2.2%
Annualized volatility68.7%54.6%
Value at risk (95%)-4%-5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, RVMD or RYTM?

On the Algovestiq AIQ Score, RYTM is the stronger of the two as of Nov 15, 2026, scoring 62 against RVMD's 55. The edge comes from quality and value. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is RVMD or RYTM the better buy right now?

RYTM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor RYTM over RVMD?

The composite weights Quality, Value, Momentum and Risk Resilience. RYTM leads Quality by 17 points; RYTM leads Value by 13 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, RVMD or RYTM?

Analyst price targets imply +52.3% upside for RVMD and +18.5% for RYTM, so the Street currently favors RVMD. That points the opposite way to the AIQ Score, which favors RYTM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, RVMD or RYTM?

RYTM is the better-valued of the two on the peer-relative Value factor. RYTM on the peer-relative Value factor, by 13 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, RVMD or RYTM?

RYTM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, RVMD or RYTM?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, RVMD or RYTM?

RVMD is the more resilient of the two, so the other name carries the higher downside risk. RVMD carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is RVMD more profitable than RYTM?

RVMD leads on the comparable margin measures — gross margin 95.2% vs 88.2%; operating margin -8.5% vs -66.7%; ttm roe -17% vs -20.5%.

Is RYTM's lead over RVMD getting stronger or weaker?

RYTM lead: Reversed — RVMD led by 9 AIQ points 30 sessions ago; RYTM now leads by 7. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-11, when RYTM moved ahead of RVMD.

What would change the RVMD vs RYTM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RVMD closes the Quality gap — currently 17 points behind, the largest single contributor to RYTM's edge; RVMD's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; RYTM's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about RVMD and RYTM?

RVMD: 3 bullish / 3 bearish / 1 neutral, conflicted. RYTM: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RVMD is Golden Cross Active (bullish, long horizon). On RYTM it is Death Cross Active (bearish, long horizon).

Compare RVMD and RYTM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.